Last reviewed · How we verify
NCT07427771
Feasibility and Acceptability of the Asynchronous eParenting CARE Program
NA trial testing eParenting CARE Program in Emotion Regulation Abilities in 67 participants. Completed in 31 August 2024.
31 August 2024
Quick facts
| Lead sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 67 |
| Start date | 1 January 2024 |
| Primary completion | 31 August 2024 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- eParenting CARE Program
Conditions studied
- Emotion Regulation Abilities — all drugs for Emotion Regulation Abilities →
- Mental Health — all drugs for Mental Health →
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Who can join
Eligibility, any sex, with Emotion Regulation Abilities or Mental Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the feasibility and acceptability of the eParenting CARE Program, an asynchronous, self-guided emotion-focused parenting intervention for parents of school-aged children (8-13 years). The eParenting CARE Program focuses on strengthening parent emotion regulation (ER) and supportive emotion socialization (ES) practices to promote children's ER and emotional well-being. Parent ER and ES are well-established predictors of children's emotional development, and difficulties in these domains are associated with increased risk for child emotional and behavioural problems. The long-term goal of this work is to improve family well-being and children's emotional functioning by developing an accessible and scalable online parenting intervention that can be delivered flexibly and with minimal barriers to participation. This pilot study will inform the refinement and future evaluation of the eParenting CARE Program through a feasibility-focused design. We will achieve this through the following key objectives: 1. Assess the feasibility and acceptability of the eParenting CARE Program for parents of school-aged children using indicators of recruitment, retention, program completion, and participant satisfaction. 2. Examine exploratory pre- to post-intervention changes in parent ER, parent ES behaviours, and parent-reported child ER to inform outcome selection and effect size estimation for future randomized controlled trials. 3. Identify implementation facilitators and barriers to participation in an asynchronous parenting program through qualitative feedback, including recommendations for improving engagement, accessibility, and program delivery. Findings from this pilot study will inform the development of future controlled trials and support the broader dissemination of accessible, emotion-focused parenting interventions aimed at promoting emotional well-being in parents and children.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07427771
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other McGill University Health Centre/Research Institute of the McGill University Health Centre trials
Trials by the same sponsor.
- NCT07439406 — Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy · Phase 2 · not yet recruiting
- NCT07328971 — Vancomycin Taper to Prevent Recurrent Clostridioides Difficile · Phase 3 · not yet recruiting
- NCT07556952 — Dex & Mastectomy Pain · Phase 4 · recruiting
- NCT07069582 — Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women · Phase 1 · not yet recruiting
- NCT07386171 — Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07427771 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre
- Last refreshed: 23 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07427771.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing